Under the drug maker's proposal, plaintiffs would have to first establish that Suboxone film strips cause tooth decay and dental erosion, before any case-specific discovery begins in the recently established Suboxone MDL.
Although plaintiffs' lawyers have proposed a tolling agreement to avoid flooding the court with tooth decay lawsuits over the next two months, the drug maker has refused to extend any Suboxone statute of limitations deadlines.
It is expected that the Court will soon approve a Master Complaint and Short Form Complaint, which will allow new Suboxone lawsuits involving tooth decay to be filed using an abbreviated form.
Plaintiffs and defendants are working jointly on a motion which will allow new Suboxone tooth decay lawsuits to be directly filed with the MDL court.
Group of 18 Suboxone lawyers have submitted a consensus motion for the plaintiffs' leadership committee, which will take actions that benefit all individuals pursuing lawsuits over tooth decay from Suboxone
Following the centralization of all Suboxone lawsuits as part of a federal MDL, lawyers must file applications by March 1 to serve in various leadership positions during the consolidated pretrial proceedings.
U.S. JPML Determined that Suboxone tooth decay lawsuits filed throughout the federal court system will be centralized in the Northern District of Ohio for discovery and pretrial proceedings.
Use of buprenorphine, the active ingredient in Suboxone and other opioid addiction treatments, during the first trimester of pregnancy was associated with a lower risk of most congenital malformations than methadone.
Maine woman indicates in a recently filed Suboxone dental erosion lawsuit that she had to undergo extensive dental work after using the opioid addiction drug, which left her with permanently damaged teeth.
At least 15 Suboxone tooth decay lawsuits have already been filed in five different U.S. District Courts, with hundreds of additional claims under active investigation by lawyers nationwide.
